Learn More
Medchemexpress LLC Silmitasertib sodium salt (CX-4945 sodium salt) | 1309357-15-0 | 99.9% | C19H11ClN3NaO2 | 50 MG

Supplier: Medchemexpress LLC HY50855B50MG
Silmitasertib sodium salt is an orally bioavailable, highly selective, and potent CK2 inhibitor, demonstrating IC50 values of 1 nM against CK2α and CK2α'. This compound induces cell-cycle arrest and selectively promotes apoptosis in cancer cells. It also attenuates PI3K/Akt signaling, decreases pro-survival ER chaperon BIP/Grp78 expression, and suppresses activation of CK2-mediated PI3K/Akt/mTOR signaling pathways in hematological tumors.
- Orally bioavailable and potent CK2 inhibitor
- Highly selective against CK2α and CK2α' (IC50 1 nM)
- Induces cell-cycle arrest and apoptosis in cancer cells
- Attenuates PI3K/Akt signaling
- Suppresses CK2-mediated PI3K/Akt/mTOR signaling
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.